• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » A quarter of N.Y. diagnostic catheters were unnecessary, study says | MassDevice.com On Call

A quarter of N.Y. diagnostic catheters were unnecessary, study says | MassDevice.com On Call

February 5, 2014 By Arezu Sarvestani

MassDevice.com On Call

MASSDEVICE ON CALL — New York researchers unveiled in a recent report that as many as 25% of recent diagnostic catheterizations performed in state hospitals were conducted in patients who didn’t meet criteria for the procedure, as rated by newly published standards.

More than half of treated patients had no chest pain, no stress test prior to catheterization and low scores for coronary artery disease evaluations, researchers said. The standards used to determine the validity of the procedures weren’t published until after the report was released, authors noted, but the variation among hospitals – some 9% rates of inappropriate procedures and others as much as 49% – suggest that something can be done to improve patient assessments.

"It appears that there are a lot of patients who are getting this procedure who don’t really need it, and [physicians] need to look over the appropriateness criteria carefully before making a decision as to whether or not to use [it]," Dr Edward L Hannan told HeartWire. "It is an expensive procedure, and it sometimes can lead to complications [or] adverse outcomes; so . . . you shouldn’t be doing it when it doesn’t need to be done."

 MRIs can identify optimal cardiac ablation patients
Researchers say that a new method of contrast MRI may be able to determine which atrial fibrillation patients are most likely to benefit from catheter ablation, helping to clear up some of the uncertainty surrounding the procedure.
Read more

 Hospitals sue over missing Medicare pay
A group of hospitals filed a joint lawsuit against the Centers for Medicare & Medicaid Services, claiming the agency inappropriately reduced reimbursements slated for low-income patients because some of them live in nursing homes.  
Read more

 Sponge syringe aims to heal gunshot wounds
Oregon startup RevMedx is working on a syringe-like device that would inject drug-coated sponges into a gunshot wound to apply pressure and prevent bleeding out.  
Read more

 Cook Medical teams up with Purdue Research on $12M startup project
Medtech maker Cook Medical joined forces with Purdue Research Foundation to establish a $12 million investment fund to sponsor emerging life sciences companies at Purdue.  
Read more

Filed Under: Catheters, Diagnostics, Hospital Care, News Well Tagged With: On Call

More recent news

  • A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology
  • Dexcom continues advances in AI for CGM, type 2 diabetes awareness
  • Tandem continues to deliver more options, benefits for those with diabetes
  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy